"
Team:Westminster/Results
From 2012.igem.org
| Line 187: | Line 187: | ||
<img class="two-columns-image" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="440" /> | <img class="two-columns-image" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="440" /> | ||
<img class="two-columns-image" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="440" /> | <img class="two-columns-image" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="440" /> | ||
| + | <h2>Lorem Ipsum</h2> | ||
| + | <p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p> | ||
| + | <p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p> | ||
</div><!-- .two-columns --> | </div><!-- .two-columns --> | ||
</div><!-- #home-main-text --> | </div><!-- #home-main-text --> | ||
Revision as of 20:03, 25 September 2012
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
